152 related articles for article (PubMed ID: 21371597)
21. A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.
Köster H; Craan T; Brass S; Herhaus C; Zentgraf M; Neumann L; Heine A; Klebe G
J Med Chem; 2011 Nov; 54(22):7784-96. PubMed ID: 21972967
[TBL] [Abstract][Full Text] [Related]
22. The benefits of constructing leads from fragment hits.
Foloppe N
Future Med Chem; 2011 Jul; 3(9):1111-5. PubMed ID: 21806375
[TBL] [Abstract][Full Text] [Related]
23. "Virtual fragment linking": an approach to identify potent binders from low affinity fragment hits.
Crisman TJ; Bender A; Milik M; Jenkins JL; Scheiber J; Sukuru SC; Fejzo J; Hommel U; Davies JW; Glick M
J Med Chem; 2008 Apr; 51(8):2481-91. PubMed ID: 18357974
[TBL] [Abstract][Full Text] [Related]
24. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
25. Medicinal chemistry inspired fragment-based drug discovery.
Lanter J; Zhang X; Sui Z
Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
[TBL] [Abstract][Full Text] [Related]
26. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
Huber W
J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
[TBL] [Abstract][Full Text] [Related]
27. Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition.
Englert L; Silber K; Steuber H; Brass S; Over B; Gerber HD; Heine A; Diederich WE; Klebe G
ChemMedChem; 2010 Jun; 5(6):930-40. PubMed ID: 20394106
[TBL] [Abstract][Full Text] [Related]
28. Molecular library design using multi-objective optimization methods.
Nicolaou CA; Kannas CC
Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
[TBL] [Abstract][Full Text] [Related]
29. Fragment-based lead discovery using X-ray crystallography.
Hartshorn MJ; Murray CW; Cleasby A; Frederickson M; Tickle IJ; Jhoti H
J Med Chem; 2005 Jan; 48(2):403-13. PubMed ID: 15658854
[TBL] [Abstract][Full Text] [Related]
30. Structure-based development of target-specific compound libraries.
Orry AJ; Abagyan RA; Cavasotto CN
Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
[TBL] [Abstract][Full Text] [Related]
31. Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking.
Kolb P; Caflisch A
J Med Chem; 2006 Dec; 49(25):7384-92. PubMed ID: 17149868
[TBL] [Abstract][Full Text] [Related]
32. A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
Schulz MN; Fanghänel J; Schäfer M; Badock V; Briem H; Boemer U; Nguyen D; Husemann M; Hillig RC
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):156-66. PubMed ID: 21358046
[TBL] [Abstract][Full Text] [Related]
33. Methods for combinatorial and parallel library design.
Schnur DM; Beno BR; Tebben AJ; Cavallaro C
Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
[TBL] [Abstract][Full Text] [Related]
34. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
[TBL] [Abstract][Full Text] [Related]
35. Investigation of MM-PBSA rescoring of docking poses.
Thompson DC; Humblet C; Joseph-McCarthy D
J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
[TBL] [Abstract][Full Text] [Related]
36. Automated protein-ligand crystallography for structure-based drug design.
Mooij WT; Hartshorn MJ; Tickle IJ; Sharff AJ; Verdonk ML; Jhoti H
ChemMedChem; 2006 Aug; 1(8):827-38. PubMed ID: 16902937
[TBL] [Abstract][Full Text] [Related]
37. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
38. Fragment-based drug design.
Feyfant E; Cross JB; Paris K; Tsao DH
Methods Mol Biol; 2011; 685():241-52. PubMed ID: 20981527
[TBL] [Abstract][Full Text] [Related]
39. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
40. Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?
Wielens J; Headey SJ; Rhodes DI; Mulder RJ; Dolezal O; Deadman JJ; Newman J; Chalmers DK; Parker MW; Peat TS; Scanlon MJ
J Biomol Screen; 2013 Feb; 18(2):147-59. PubMed ID: 23139382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
